Research Topics
| Kari L OlsonSummaryAffiliation: Kaiser Permanente Country: USA Publications
| Collaborators
|
Detail Information
Publications
Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organizationKari L Olson
Departments of Pharmacy, Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente Colorado Region, Aurora, CO 80211, USA
Arch Intern Med 165:49-54. 2005..The aim of this study is to examine the impact of a clinical pharmacy cardiac risk service (CPCRS) on lipid screening, control, and treatment outcomes...- Outcomes of patients discharged from pharmacy-managed cardiovascular disease managementKari L Olson
Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO 80011, USA
Am J Manag Care 15:497-503. 2009..To evaluate whether patients with coronary artery disease (CAD) discharged from the Clinical Pharmacy Cardiac Risk Service (CPCRS) would maintain their lipid goals with use of an electronic laboratory reminder system... 
Publication rates of abstracts presented by pharmacy residents at the Western States ConferenceKari L Olson
Pharmacy Department, Kaiser Permanente Colorado, Aurora, 80011, USA
Am J Health Syst Pharm 69:59-62. 2012..Investigators report the results of a study to determine the proportion of residency projects presented as abstracts at a regional residency conference that were subsequently published as full-length articles...- Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary interventionKari L Olson
Pharmacy Department, Kaiser Permanente Colorado, 16601 E Centretech Parkway, Aurora, CO 80011, USA
J Thromb Thrombolysis 29:316-21. 2010..0; 95% CI 1.1-3.8). Post-stent treatment with warfarin, ASA, and clopidogrel was associated with a substantially greater likelihood of major hemorrhage than treatment with ASA and clopidogrel alone... - Factors associated with recurrent coronary events among patients with cardiovascular diseaseKaren J McConnell
Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente Colorado, Aurora, Colorado 80011, USA
Pharmacotherapy 29:906-13. 2009..To determine which factors are associated with recurrent coronary events... - Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organizationBrian G Sandhoff
Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente of Colorado KPCO, Aurora, Colorado 80011, USA
Am J Health Syst Pharm 64:77-84. 2007..A clinical pharmacy service for managing the treatment of coronary artery disease in a health maintenance organization is described... - Reduced health care expenditures after enrollment in a collaborative cardiac care serviceThomas Delate
Pharmacy Department, Kaiser Permanente Colorado, Aurora, Colorado 80011, USA
Pharmacotherapy 30:1127-35. 2010..To assess the impact of a collaborative cardiovascular risk reduction service (Collaborative Cardiac Care Service [CCCS]) on total health care expenditures after an incident acute coronary event... - Statin adherence and mortality in patients enrolled in a secondary prevention programBrandy D McGinnis
Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO 80011, USA
Am J Manag Care 15:689-95. 2009..To determine statin adherence rates in patients enrolled in a cardiovascular secondary disease prevention program and to evaluate the impact of adherence on subsequent clinical events... - Relationship between haemoglobin A1C values and recurrent cardiac events: A retrospective, longitudinal cohort studyAmy B Kauffman
Kaiser Permanente Colorado, Aurora, Colorado, USA
Clin Drug Investig 28:501-7. 2008.... - Attainment of low-density lipoprotein cholesterol goals in coronary artery diseaseAmy B Kauffman
Pharmacy Department, Kaiser Permanente Colorado, 16601 E Centretech Parkway, Aurora, CO 80011, USA
J Clin Lipidol 4:173-80. 2010..This study evaluated the extent to which this recommendation can be attained by the use of currently available lipid-lowering therapies... - Factors related to adherence to statin therapyBrandy McGinnis
Department of Pharmacy, Kaiser Permanente Colorado, Aurora, CO 80011, USA
Ann Pharmacother 41:1805-11. 2007..Retrospective database analyses have revealed that 50% of patients receiving statins discontinue therapy after one year of treatment. Typically, these data do not focus on patient-specific reasons for discontinuation... - The triglyceride-lowering effects of a modest dose of docosahexaenoic acid alone versus in combination with low dose eicosapentaenoic acid in patients with coronary artery disease and elevated triglyceridesLisa J Schwellenbach
Kaiser Permanente Colorado, Clinical Pharmacy Cardiac Risk Service, Aurora, CO 80011, USA
J Am Coll Nutr 25:480-5. 2006..There do not appear to be significant differences in triglyceride-lowering between DHA only and DHA + EPA combination products when dosing is based on DHA... - A multimodal blood pressure control intervention in 3 healthcare systemsDavid J Magid
Institute for Health Research, Kaiser Permanente Colorado, Denver, USA
Am J Manag Care 17:e96-103. 2011.... - Evaluation of cases of severe statin-related transaminitis within a large health maintenance organizationEvguenia C Charles
Clinical Pharmacy Cardiac Risk Service, Kaiser Permanente of Colorado, Denver, Colorado, USA
Am J Med 118:618-24. 2005..These findings support less frequent liver enzyme monitoring for most patients on statins. Continued monitoring remains warranted for patients on concomitant medications or those with comorbid conditions... - Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery diseaseJohn A Merenich
Department of Endocrinology, Colorado Permanente Medical Group, Denver, Colorado, USA
Pharmacotherapy 27:1370-8. 2007..To determine the effect of early and sustained enrollment in a comprehensive cardiac care (CCC) program on all-cause mortality in patients with coronary artery disease (CAD)... 
Out-of-plan pharmacy use by members of a managed care organizationThomas Delate
Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO, USA
Perm J 16:15-21. 2012..Little is known about the use of these programs. The purpose of this study was to assess the rate and characteristics of prescriptions written in a managed care organization (MCO) to an out-of-plan pharmacy (OOPP)...- Clinical and economic outcomes of conversion of simvastatin to lovastatin in a group-model health maintenance organizationSarah J Billups
Kaiser Permanente Central Support Services, 16601 East Centretech Pkwy, Aurora, CO 80011, USA
J Manag Care Pharm 11:681-6. 2005.... - Assessment of patient satisfaction with telephone and mail interventions provided by a clinical pharmacy cardiac risk reduction serviceSusan L Holsclaw
Kaiser Foundation Health Plan of Colorado, 16601 East Centretech Parkway, Aurora, CO 80011, USA
J Manag Care Pharm 11:403-9. 2005..CPCRS provides much of its care via telephone. The purpose of this study was to determine the level of satisfaction among patients in this unique service... - An assessment of cholesterol goal attainment in patients with chronic kidney diseaseSheila L Stadler
Pharmacy Department, Kaiser Permanente Colorado, 16601 East Centretech Parkway, Aurora, CO 80011, USA
J Clin Lipidol 4:298-304. 2010..The National Kidney Foundation developed clinical practice guidelines (Kidney Disease Outcomes Quality Initiative) for targeting low-density lipoprotein cholesterol (LDL-C) goals... - Self-reported inhaler use in patients with chronic obstructive pulmonary diseaseKory VanderSchaaf
Pharmacy Department, Kaiser Permanente Colorado, Aurora, CO, USA
Respir Med 104:99-106. 2010..Higher education level, home oxygen use and prescriptions for ipratropium were predictors for inhaler variance. The impact of inhaler variance on morbidity of COPD should be evaluated... - Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery diseaseP Michael Ho
Cardiology Section, Denver VA Medical Center, Denver, CO, USA
Am Heart J 155:772-9. 2008..Little is known about the effect of nonadherence among patients with coronary artery disease (CAD) on a broad spectrum of outcomes including cardiovascular mortality, cardiovascular hospitalizations, and revascularization procedures... - Monitoring of patients given second-generation antipsychotic agentsKari L Olson
Psychiatr Serv 57:1045-6. 2006 - Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary diseaseP Michael Ho
Cardiology Section, Denver Veterans Affairs Medical Center, 1055 Clermont St, Denver, CO 80220, USA
Arch Intern Med 168:271-6. 2008..Despite the importance of blood pressure (BP) control in secondary prevention, a significant proportion of patients with coronary disease have uncontrolled BP... - Effect of community pharmacist intervention on cholesterol levels in patients at high risk of cardiovascular events: the Second Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP-plus)Ross T Tsuyuki
Department of Medicine, University of Alberta, Edmonton, Alberta, Canada
Am J Med 116:130-3. 2004 - Patients' achievement of cholesterol targets: a cross-sectional evaluationKari L Olson
Epidemiology Coordinating and Research Centre, Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada T6G 2C8
Am J Prev Med 25:339-42. 2003..This suggests a need for more-aggressive approaches to the management of cholesterol, particularly in high-risk patients...